Clinical trial
Determining the Feasibility of Spinal Cord Neuromodulation for the Treatment of Chronic Heart Failure
NCT01112579 is registered in ClinicalTrials.gov with Medtronic Cardiac Rhythm and Heart Failure as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Determining the Feasibility of Spinal Cord Neuromodulation for the Treatment of Chronic Heart Failure
- Lead sponsor
- Medtronic Cardiac Rhythm and Heart Failure
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 30, 2010
- Completion date
- April 30, 2015
- Enrollment
- 81 (actual)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.